Stomach Cancer

Dr. Travis Grotz discusses how hyperthermic intraperitoneal chemotherapy (HIPEC) works and the potential benefits of the treatment.

Mayo Clinic study shows a new approach to chemotherapy more than doubles the typical survival rate for people with stomach cancer.

Dr. Travis Grotz, a Mayo Clinic surgical oncologist, explains the symptoms, diagnosis and treatment of stomach cancer.

Researchers have identified a gene biomarker associated with overall survival and treatment response in people with gastric cancer.

The story of 39-year-old Stacy Weisensel's diagnosis of stomach cancer and her treatment journey at Mayo Clinic.

Dr. Travis Grotz explains how hyperthermic intraperitoneal chemotherapy works and how it can help patients with certain late-stage cancers.

Oncologist Dr. Mohamad Sonbol explains why there is hope for people with stomach cancer as treatments improve.

A new blog series to raise awareness about clinical trials and their important role in cancer care.

Wendy Sherman, M.D., discusses using liquid biopsy to care for people with breast, lung and gastric cancer that has spread to the brain and spinal cord.

Researchers are investigating whether immunotherapy benefits people with esophageal and gastric cancers that have not spread to distant organs.